Prevention of prostate cancer through custom tailoring of chemopreventive regimen
- 30 January 2008
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 171 (2) , 122-132
- https://doi.org/10.1016/j.cbi.2007.03.001
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move ForwardClinical Cancer Research, 2006
- The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivoProstate Cancer and Prostatic Diseases, 2006
- Anthocyanin‐ and hydrolyzable tannin‐rich pomegranate fruit extract modulates MAPK and NF‐κB pathways and inhibits skin tumorigenesis in CD‐1 miceInternational Journal of Cancer, 2004
- Cell Cycle Arrest and Induction of Apoptosis by Lycopene in LNCaP Human Prostate Cancer CellsJournal of Medicinal Food, 2004
- NITRIC OXIDE DONATING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS INDUCE APOPTOSIS IN HUMAN PROSTATE CANCER CELL SYSTEMS AND HUMAN PROSTATIC STROMA VIA CASPASE-3Journal of Urology, 2004
- Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer CellsMolecular Biology of the Cell, 2004
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- A Population-Based Study of Daily Nonsteroidal Anti-inflammatory Drug Use and Prostate CancerMayo Clinic Proceedings, 2002
- Lycopene in Association with α-Tocopherol Inhibits at Physiological Concentrations Proliferation of Prostate Carcinoma CellsBiochemical and Biophysical Research Communications, 1998
- Ornithine decarboxylase as a target for chemopreventionJournal of Cellular Biochemistry, 1995